149 related articles for article (PubMed ID: 10608720)
1. Extracorporeal treatment of thrombotic microangiopathy: a ten year experience.
Bueno D; Sevigny J; Kaplan AA
Ther Apher; 1999 Nov; 3(4):294-7. PubMed ID: 10608720
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal plasma treatment in thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: a review.
Bosch T; Wendler T
Ther Apher; 2001 Jun; 5(3):182-5. PubMed ID: 11467754
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the 10-year experience of a single center.
Kim JW; Kim I; Oh KH; Yoon SS; Oh MD; Song YW; Heo DS; Bang YJ; Han KS; Han JS; Park S; Kim BK
Hematology; 2011 Mar; 16(2):73-9. PubMed ID: 21418736
[TBL] [Abstract][Full Text] [Related]
4. [Clinical management of hemolytic-uremic syndrome and thrombotic-thrombocytopenic purpura].
Keller F; Schwarze H; Schwarz A
Wien Klin Wochenschr; 1994; 106(19):603-7. PubMed ID: 7998406
[TBL] [Abstract][Full Text] [Related]
5. Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma.
Snyder HW; Mittelman A; Oral A; Messerschmidt GL; Henry DH; Korec S; Bertram JH; Guthrie TH; Ciavarella D; Wuest D
Cancer; 1993 Mar; 71(5):1882-92. PubMed ID: 8448753
[TBL] [Abstract][Full Text] [Related]
6. Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies.
von Baeyer H
Ther Apher; 2002 Aug; 6(4):320-8. PubMed ID: 12164804
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation.
Sarode R; McFarland JG; Flomenberg N; Casper JT; Cohen EP; Drobyski WR; Ash RC; Horowitz MM; Camitta B; Lawton C
Bone Marrow Transplant; 1995 Aug; 16(2):271-5. PubMed ID: 7581147
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
Clark WF
Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
[TBL] [Abstract][Full Text] [Related]
9. [Thrombotic microangiopathy: when time is the key factor!].
Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
[TBL] [Abstract][Full Text] [Related]
10. Plasmapheresis for thrombotic thrombocytopenic purpura following bone marrow transplantation.
Kolker O; Sviri S; Linton DM; Or R; Nagler A; Shapira MY
Acta Haematol; 2001; 105(3):156-8. PubMed ID: 11463989
[TBL] [Abstract][Full Text] [Related]
11. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
Shibagaki Y; Fujita T
Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
[TBL] [Abstract][Full Text] [Related]
12. Improved survival with plasma exchange in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Lara PN; Coe TL; Zhou H; Fernando L; Holland PV; Wun T
Am J Med; 1999 Dec; 107(6):573-9. PubMed ID: 10625026
[TBL] [Abstract][Full Text] [Related]
13. Protein A immunoadsorption therapy for refractory, mitomycin C-associated thrombotic microangiopathy.
Kasper S; Neurath MF; Huber C; Theobald M; Scharrer I
Transfusion; 2007 Jul; 47(7):1263-7. PubMed ID: 17581162
[TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Hayward CP; Sutton DM; Carter WH; Campbell ED; Scott JG; Francombe WH; Shumak KH; Baker MA
Arch Intern Med; 1994 May; 154(9):982-7. PubMed ID: 8179455
[TBL] [Abstract][Full Text] [Related]
15. Primary and Secondary Thrombotic Microangiopathy Referred to a Single Plasma Exchange Center for Suspected Thrombotic Thrombocytopenic Purpura: 2000-2011.
Dahlan R; Sontrop JM; Li L; Ghadieh O; Clark WF
Am J Nephrol; 2015; 41(6):429-37. PubMed ID: 26183258
[TBL] [Abstract][Full Text] [Related]
16. Re-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.
Bittencourt CE; Ha JP; Maitta RW
PLoS One; 2015; 10(5):e0127744. PubMed ID: 26000799
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak.
Dundas S; Murphy J; Soutar RL; Jones GA; Hutchinson SJ; Todd WT
Lancet; 1999 Oct; 354(9187):1327-30. PubMed ID: 10533860
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and outcome of Chinese patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: a 9-year retrospective study.
Zhang W; Shi H; Ren H; Shen PY; Pan XX; Li X; Chen YX; Xu YW; Chen XN; Zhu P; Chen N
Nephron Clin Pract; 2009; 112(3):c177-83. PubMed ID: 19439988
[TBL] [Abstract][Full Text] [Related]
19. Plasma exchange and vincristine in the treatment of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura associated with bone marrow transplantation.
Silva VA; Frei-Lahr D; Brown RA; Herzig GP
J Clin Apher; 1991; 6(1):16-20. PubMed ID: 2045377
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of thrombotic microangiopathies].
Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D
Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
